JP2004503233A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503233A5
JP2004503233A5 JP2002510516A JP2002510516A JP2004503233A5 JP 2004503233 A5 JP2004503233 A5 JP 2004503233A5 JP 2002510516 A JP2002510516 A JP 2002510516A JP 2002510516 A JP2002510516 A JP 2002510516A JP 2004503233 A5 JP2004503233 A5 JP 2004503233A5
Authority
JP
Japan
Prior art keywords
den
protein
residues
sequence
ectodomain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002510516A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004503233A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2001/001570 external-priority patent/WO2001096376A2/en
Publication of JP2004503233A publication Critical patent/JP2004503233A/ja
Publication of JP2004503233A5 publication Critical patent/JP2004503233A5/ja
Pending legal-status Critical Current

Links

Images

JP2002510516A 2000-06-16 2001-06-18 デング熱ウイルスエンベロープ糖タンパク質のプロ−アポトーシスフラグメント Pending JP2004503233A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21212900P 2000-06-16 2000-06-16
PCT/IB2001/001570 WO2001096376A2 (en) 2000-06-16 2001-06-18 Pro-apoptotic fragments of the dengue virus envelope glycoproteins

Publications (2)

Publication Number Publication Date
JP2004503233A JP2004503233A (ja) 2004-02-05
JP2004503233A5 true JP2004503233A5 (https=) 2005-02-03

Family

ID=22789669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002510516A Pending JP2004503233A (ja) 2000-06-16 2001-06-18 デング熱ウイルスエンベロープ糖タンパク質のプロ−アポトーシスフラグメント

Country Status (6)

Country Link
US (2) US6673895B2 (https=)
EP (1) EP1311539A2 (https=)
JP (1) JP2004503233A (https=)
AU (1) AU2001282388A1 (https=)
CA (1) CA2412257A1 (https=)
WO (1) WO2001096376A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1152402A (en) * 2000-10-04 2002-04-15 Univ Pennsylvania Highly expressible genes
US7189403B2 (en) * 2003-06-30 2007-03-13 Institut Pasteur Attenuated flavivirus strains containing a mutated M-ectodomain and their applications
CA2508266A1 (fr) 2005-06-20 2006-12-20 Institut Pasteur Polypeptides chimeriques et leurs applications therapeutiques contre une infection a flaviviridae
ES2423518T3 (es) 2006-12-22 2013-09-20 Institut Pasteur Células y metodología para generar virus de ARN de cadena de sentido negativo no segmentada

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136561A (en) * 1995-05-24 2000-10-24 Hawaii Biotechnology Group, Inc. Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems
CA2290090A1 (fr) * 1999-12-07 2001-06-07 Marie-Pierre Courageot Lignee cellulaire stable inductible n2aprm+e incluant l'adnc codant pour les glycoproteines prm et e du virus den-1: un systeme modele pour tester les proprietes inhibitrices des agents anti-viraux cibles pour les glycoproteines de l'enveloppe des flaviviridae

Similar Documents

Publication Publication Date Title
Hüssy et al. Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase
Suzich et al. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes
Ryan et al. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing
JP2002510494A5 (https=)
CA2443323A1 (en) Nucleic acid vaccines for prevention of flavivirus infection
WO2002089731A3 (en) Agents for treatment of hcv and methods of use
DE69534600D1 (de) Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
Totsuka et al. Hepatitis A virus proteins
US5830691A (en) Method of producing ectoprotein of hepatitis C virus
JP3045778B2 (ja) Ｃ型肝炎ウイルスプロテアーゼの不溶性凝集物をリフォールディングするための方法
JP2004503233A5 (https=)
CA2070952A1 (en) Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
MY135991A (en) A vaccine-induced hepatits b viral strain and uses thereof
US6022685A (en) Methods and compositions for detecting anti-hepatitis E virus activity
Yasumasa et al. Processing of hepatitis C viral polyprotein in Escherichia coli
RU2214273C2 (ru) ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ, КОДИРУЮЩИЕ ЧЕЛОВЕЧЕСКИЕ ПРОТЕИНЫ Tx И Ty, РОДСТВЕННЫЕ КОНВЕРГИРУЮЩЕМУ ИНТЕРЛЕЙКИН-1-β ФЕРМЕНТУ
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
Lorenzo et al. Expression and immunological evaluation of the Escherichia coli‐derived hepatitis C virus envelope E1 protein
Dueñas‐Carrera et al. Immunization with a DNA vaccine encoding the hepatitis‐C‐virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and Macaca irus (crab‐eating macaque monkeys)
GR3015437T3 (en) Non-a non-b sequences.
Seal et al. Predicted stem-loop structures and variation in nucleotide sequence of 3′ noncoding regions among animal calicivirus genomes
KR100304133B1 (ko) C형간염바이러스단백질분해효소의기질로사용되는융합단백질및이를이용한단백질분해효소의활성측정방법
CA2330935C (en) A mutant human hepatitis b viral strain and uses thereof
Lundström et al. Secretion of Semliki Forest virus membrane glycoprotein El from Bacillus subtilis
AU684478C (en) Methods and compositions for detecting anti-hepatitis E virus activity